[Interactions between X-rays and antimitotic drugs: cellular effects (author's transl)]

Area of Science:

• * Cellular and Molecular Biology
• * Radiation Oncology
• * Pharmacology

Background:

• * Understanding drug-X-ray interactions is crucial for optimizing cancer radiotherapy.
• * Rat hepatoma cells provide an in vitro model to study cellular responses to genotoxic agents.

Purpose of the Study:

• * To investigate the combined effects of Daunomycine, 9-hydroxy ellipticine, and cis-diamminedichloroplatinum(II) (cis-Pt(II)) with X-ray irradiation on rat hepatoma cells.
• * To determine the impact of these drugs on cell survival and DNA damage repair mechanisms.

Main Methods:

• * In vitro incubation of rat hepatoma cells with Daunomycine, 9-hydroxy ellipticine, or cis-Pt(II).
• * Exposure of cells to X-ray irradiation under varying conditions (anoxia, pre-incubation).
• * Assessment of cell survival rates and analysis of potentially lethal and sublethal damage repair.

Main Results:

• * Daunomycine and 9-hydroxy ellipticine reduced survival in both exponential and plateau-phase cells.
• * Cis-Pt(II) decreased survival in plateau-phase cells, particularly when irradiated under anoxia.
• * All three drugs inhibited the repair of potentially lethal damage, with cis-Pt(II) also inhibiting sublethal damage repair.

Conclusions:

• * Daunomycine, 9-hydroxy ellipticine, and cis-Pt(II) enhance the cytotoxic effects of X-rays in rat hepatoma cells.
• * These drugs interfere with cellular DNA repair mechanisms, suggesting potential as radiosensitizers in cancer therapy.
• * Differential effects on cell cycle phases and damage repair highlight the complexity of drug-X-ray interactions.